| Dec 14 2023 |
President Seeks More Antitrust Scrutiny of Health Care Transactions |
Epstein Becker & Green, P.C. |
| Dec 14 2023 |
If the Label Is Skinny Enough – No Inducement Under Hatch-Waxman |
McDermott Will & Schulte LLP |
| Dec 14 2023 |
EPA’s Proposed Registration of a Sprayable RNAi Biopesticide — A Conversation with Meibao Zhuang, Ph.D. [Podcast] |
Bergeson & Campbell, P.C. |
| Dec 14 2023 |
ECHA Calls for Evidence on Certain Chromium (VI) Substances |
Bergeson & Campbell, P.C. |
| Dec 13 2023 |
Federal Circuit Evaluates Impact of the Final Written Decision (FWD) in a Parallel Inter-Partes Review (IPR) on District Court’s decision of Invalidity and Infringement |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 13 2023 |
AMCC Awards Five Integrated Licenses, Chaos to Follow |
Bradley Arant Boult Cummings LLP |
| Dec 13 2023 |
M&A Primer for Emerging Healthy F&B Companies |
Foley & Lardner LLP |
| Dec 13 2023 |
FDA Announces Draft Supplemental Guidance on Menu Labeling |
Keller and Heckman LLP |
| Dec 12 2023 |
US House Introduces Bipartisan Feed Ingredient Bill |
Keller and Heckman LLP |
| Dec 12 2023 |
Korea Introduces More Rules to Enhance Oversight of Alternative Protein Foods |
Keller and Heckman LLP |
| Dec 11 2023 |
The March on Pharmaceutical Patents? |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 8 2023 |
EC Committee Begins Public Consultation on Its Preliminary Opinion for Titanium Dioxide |
Bergeson & Campbell, P.C. |
| Dec 8 2023 |
FDA Approves Two Gene Therapies to Treat Sickle Cell Disease Including a CRISPR-Based Therapy |
Foley & Lardner LLP |
| Dec 8 2023 |
McDermottPlus Check-Up: December 8, 2023 |
McDermott Will & Schulte LLP |
| Dec 8 2023 |
China on the Move: Fine-Tuning the Life Sciences Regulatory and Compliance Landscape |
Greenberg Traurig, LLP |
| Dec 8 2023 |
Prolific Plaintiff’s Lawyer Held in Contempt |
Keller and Heckman LLP |
| Dec 8 2023 |
Hospital Executive and Three Physicians to Pay More Than $880,000 to Resolve Kickback Allegations |
ArentFox Schiff LLP |
| Dec 8 2023 |
Illinois Supreme Court: Finger-Scan Information Collected by Healthcare Providers to Access Medications Is Exempt From BIPA Liability |
McDermott Will & Schulte LLP |
| Dec 7 2023 |
Win for Healthcare Institutions: Illinois High Court Rules Healthcare Employees’ Biometrics Exempt from BIPA Requirements |
Squire Patton Boggs (US) LLP |
| Dec 7 2023 |
Total Wine Tests the Boundaries of FTC CIDs |
McDermott Will & Schulte LLP |
| Dec 7 2023 |
Missouri Bill Proposed to Preempt California’s Proposition 12 |
Keller and Heckman LLP |
| Dec 6 2023 |
White House OSTP and NNCO Announce Series of Events in Celebration of 20th Anniversary of the Authorization of the NNI |
Bergeson & Campbell, P.C. |
| Dec 6 2023 |
Decentralized Clinical Trials: Diversity in Clinical Trials |
Foley & Lardner LLP |
| Dec 6 2023 |
This Week in 340B: November 28 – December 5, 2023 |
McDermott Will & Schulte LLP |
| Dec 6 2023 |
FDA’s Final Rule on Direct-to-Consumer Advertising – Presentation of Risk Information |
Foley & Lardner LLP |
| Dec 6 2023 |
Ten Highlights from the Environmental and Energy Space in 2023 |
ArentFox Schiff LLP |
| Dec 5 2023 |
Council On Supply Chain Resilience Tasked With Strengthening Domestic Supply Chains And Limiting Reliance On Foreign Medical Supplies |
Squire Patton Boggs (US) LLP |
| Dec 5 2023 |
Episode 30: Let’s Talk Compliance: Medical Device and Physician Arrangements [Podcast] |
Foley & Lardner LLP |
| Dec 5 2023 |
FDA Study Finds Biosimilars Are Interchangeable |
ArentFox Schiff LLP |
| Dec 5 2023 |
Proposed Amendments to the Proposition 65 Regulatory Landscape – Changes to Clear and Reasonable Warnings and Safe Harbor Methods under Article 6 |
Foley & Lardner LLP |
| Dec 5 2023 |
Unpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic |
Epstein Becker & Green, P.C. |
| Dec 5 2023 |
USDA-AMS Updates List of Bioengineered Foods |
Keller and Heckman LLP |
| Dec 5 2023 |
Biden Administration Prioritizing Domestic Production of Pharmaceuticals . . . Again? |
Blank Rome LLP |
| Dec 4 2023 |
Report Spotlights Legal Risks of Biodiversity Loss in Agricultural, Seafood Industries |
Cadwalader, Wickersham & Taft LLP |
| Dec 4 2023 |
laAPHIS Announces Determination of Nonregulated Status for Insect-Resistant and Herbicide-Tolerant Maize |
Bergeson & Campbell, P.C. |
